Meyer-Rienecker H
Psychiatr Neurol Med Psychol (Leipz). 1976 Nov;28(11):641-53.
Starting from the knowledge accumulated with respect to the etiopathogenesis and the components of immunoreaction a minimal to maximal program by steps has been developed for the cerebrospinal fluid (CSF) in multiple sclerosis (MS). It is based on fundamental methods (I), special supplementary methods (II), and relatively specific immunological methods (III). For MS five possible conditions of the CSF could be determined from alterations of cells and variations in protein: a (1) typically complete and (2.) typically incomplete immunoreactive encephalomyelitic (encephalitic) syndrome, a (3.) nonspecific CSF-syndrome of low degree and less typical character (in the sense of an acute or subacute irritation syndrome) an (4.) atypical syndrome of a considerable degree, and a (5.) normal condition of the cerebrospinal fluid. The significance of immunoreactive cerebrospinal fluid syndromes to the diagnostic criteria of multiple sclerosis as well as further relatively disease-specific methods (such as the MEM test and MSF assay) of determining cellular immunity, are discussed.
基于在病因发病机制和免疫反应成分方面积累的知识,针对多发性硬化症(MS)患者的脑脊液(CSF),已逐步制定了一个从最小到最大的检测方案。该方案基于基础方法(I)、特殊补充方法(II)和相对特异的免疫学方法(III)。根据细胞变化和蛋白质变异情况,可确定MS患者脑脊液的五种可能状态:a(1)典型的完全性和(2)典型的不完全性免疫反应性脑脊髓炎(脑炎性)综合征;a(3)低度且不太典型的非特异性脑脊液综合征(急性或亚急性刺激综合征);a(4)相当程度的非典型综合征;以及a(5)脑脊液正常状态。文中还讨论了免疫反应性脑脊液综合征对多发性硬化症诊断标准的意义,以及进一步的相对疾病特异性方法(如MEM试验和MSF检测)在确定细胞免疫方面的作用。